Alternative mutations of a positively selected residue elicit gain or loss of functionalities in enzyme evolution.

All molecular species in an organism are connected physically and functionally to other molecules. In evolving systems, it is not obvious to what extent functional properties of a protein can change to selective advantage and leave intact favorable traits previously acquired. This uncertainty has particular significance in the evolution of novel pathways for detoxication, because an organism challenged with new xenobiotics in the environment may still require biotransformation of previously encountered toxins. Positive selection has been proposed as an evolutionary mechanism for facile adaptive responses of proteins to changing conditions. Here, we show, by saturation mutagenesis, that mutations of a hypervariable residue in human glutathione transferase M2-2 can differentially change the enzyme's substrate-activity profile with alternative substrates and, furthermore, enable or disable dissimilar chemical reactions. Crystal structures demonstrate that activity with epoxides is enabled through removal of steric hindrance from a methyl group, whereas activities with an orthoquinone and a nitroso donor are maintained in the variant enzymes. Given the diversity of cellular activities in which a single protein can be engaged, the selective transmutation of functional properties has general significance in molecular evolution.

[1]  M. Pincus,et al.  Regulation of JNK signaling by GSTp , 1999, The EMBO journal.

[2]  B. Mannervik,et al.  Regio- and enantioselectivities in epoxide conjugations are modulated by residue 210 in Mu class glutathione transferases. , 2005, Protein engineering, design & selection : PEDS.

[3]  W. Pearson,et al.  Identification of Residues in Glutathione Transferase Capable of Driving Functional Diversification in Evolution , 2003, The Journal of Biological Chemistry.

[4]  J. Bishop Directed mutagenesis confirms the functional importance of positively selected sites in polygalacturonase inhibitor protein. , 2005, Molecular biology and evolution.

[5]  W. Pearson,et al.  Nomenclature for mammalian soluble glutathione transferases. , 2005, Methods in enzymology.

[6]  V S Lamzin,et al.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. , 1997, Acta crystallographica. Section D, Biological crystallography.

[7]  J. C. Greene,et al.  Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Nielsen,et al.  Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. , 1998, Genetics.

[9]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[10]  Michael Emerman,et al.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[12]  C. Welch,et al.  Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite Aminochrome* , 1997, The Journal of Biological Chemistry.

[13]  M. Maines Current protocols in toxicology , 1999 .

[14]  P. Simons,et al.  Purification of glutathione S-transferases by glutathione-affinity chromatography. , 1981, Methods in enzymology.

[15]  Joseph P Bielawski,et al.  Accuracy and power of bayes prediction of amino acid sites under positive selection. , 2002, Molecular biology and evolution.

[16]  Paul S Bernstein,et al.  Identification and Characterization of a Pi Isoform of Glutathione S-Transferase (GSTP1) as a Zeaxanthin-binding Protein in the Macula of the Human Eye* , 2004, Journal of Biological Chemistry.

[17]  N. Goldman,et al.  Codon-substitution models for heterogeneous selection pressure at amino acid sites. , 2000, Genetics.

[18]  S. Chung,et al.  Glutathione S-transferase and S-crystallins of cephalopods: Evolution from active enzyme to lens-refractive proteins , 1995, Journal of Molecular Evolution.

[19]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[20]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[21]  O. Béjà,et al.  Darwinian adaptation of proteorhodopsin to different light intensities in the marine environment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Finley,et al.  Tumor-suppressive Maspin Regulates Cell Response to Oxidative Stress by Direct Interaction with Glutathione S-Transferase* , 2005, Journal of Biological Chemistry.

[23]  B. Mannervik,et al.  Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. , 2000, Biochemical and biophysical research communications.

[24]  David L. Robertson,et al.  Comparative Study of Adaptive Molecular Evolution in Different Human Immunodeficiency Virus Groups and Subtypes , 2004, Journal of Virology.

[25]  H. Jörnvall,et al.  Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Edward C Holmes,et al.  High rate of viral evolution associated with the emergence of carnivore parvovirus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[28]  B. Ketterer,et al.  Ligandin: a Hepatic Protein which Binds Steroids, Bilirubin, Carcinogens and a Number of Exogenous Organic Anions , 1971, Nature.